Cellular and T cell engager Immunotherapy
Comparative Efficacy of CARVYKTI in CARTITUDE-4 versus Alternative Treatments from Daratumumab Clinical Trials for the Treatment of Patients with Lenalidomide-Refractory Multiple Myeloma
Michel Delforge, MD/Phd (he/him/his)
Professor of Medicine
University of Leuven, Leuven, Belgium
Leuven, Belgium